Krendyukov, A.
Schiestl, M.
Höbel, N.
Aapro, M.
Funding for this research was provided by:
Sandoz GmbH
Article History
Received: 26 June 2017
Accepted: 16 August 2017
First Online: 20 September 2017
Compliance with ethical standards
:
: Matti Aapro: Amgen (honoraria, speakers bureau, expert testimony), Helsinn Healthcare (advisory role, speakers bureau, research funding), Hospira (advisory role, speakers bureau, research funding), Teva (advisory role, speakers bureau), Merck KGaA (advisory role), Merck (advisory role), Sandoz (advisory role, speakers bureau, research funding), Pierre Fabre Medicament (advisory role, speakers bureau, research funding), Vifor Pharma (advisory role, speakers bureau), Tesaro (advisory role, speakers bureau), Novartis (speakers bureau, research funding), Roche (speakers bureau), Johnson & Johnson (speakers bureau)Andriy Krendyukov: Hexal AG (employment)Martin Schiestl: Hexal AG (employment)Nadia Hoebel: Hexal AG (employment)